tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Drugmakers criticize Trump drug price negotiation plan, Bloomberg reports
PremiumThe FlyDrugmakers criticize Trump drug price negotiation plan, Bloomberg reports
11d ago
Pharma cos criticize Trump’s drug price negotiation plan, Bloomberg Law reports
Premium
The Fly
Pharma cos criticize Trump’s drug price negotiation plan, Bloomberg Law reports
11d ago
Kymera Therapeutics assumed with an Overweight at Morgan Stanley
Premium
The Fly
Kymera Therapeutics assumed with an Overweight at Morgan Stanley
16d ago
Sanofi’s Promising Drug Pipeline and Undervaluation Drive Buy Rating
PremiumRatingsSanofi’s Promising Drug Pipeline and Undervaluation Drive Buy Rating
22d ago
Kymera Therapeutics price target raised to $59 from $55 at BTIG
Premium
The Fly
Kymera Therapeutics price target raised to $59 from $55 at BTIG
23d ago
Kymera weakness a buying opportunity, says Stifel
Premium
The Fly
Kymera weakness a buying opportunity, says Stifel
24d ago
Buy Rating for Sanofi Driven by Promising Amlitelimab Phase III Trials and Competitive Positioning
PremiumRatingsBuy Rating for Sanofi Driven by Promising Amlitelimab Phase III Trials and Competitive Positioning
1M ago
Regeneron, Sanofi announce Dupixent outperformed Xolair
Premium
The Fly
Regeneron, Sanofi announce Dupixent outperformed Xolair
1M ago
Senators to propose ban on drug ads to consumers, WSJ reports
Premium
The Fly
Senators to propose ban on drug ads to consumers, WSJ reports
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100